missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Human Recombinant IL-18 BPa
Click to view available options
Quantity:
10 μg
1000 μg
50 μg
Unit Size:
1000µg
10µg
50µg
Description
- Interleukin 18 binding protein (IL-18 BP) is a glycoprotein that contains a single IgG domain (C2-type)
- In humans, alternative splicing of the mRNA results in at least four different isoforms being generated; the most-expressed form in humans is IL-18 BPa (Dinarello et al.; Kim et al.) IL-18 BPa inhibits pro-inflammatory cytokine IL-18 by preventing it from binding to its receptor, thereby inhibiting IL-18-induced IFN-gamma production; the binding of IL-18 BPa to IL-18 is primarily due to the Ig domain (Carrascal et al.; Dinarello et al.) IL-18 is associated with an increase in cell adhesion molecules, chemokine production, stimulating vascular endothelial cells, metastatic tumor cell invasion, autoimmune diseases, emphysema, metabolic syndromes, Crohn's disease, psoriasis, and has also been implicated in a role in heart disease (Dinarello et al.) Some studies have also shown that blocking of IL-18 activity can reduce metastasis in mouse models of melanoma (Carrascal et al.)
Specifications
Specifications
| Name | IL18BP, Tadekinig alfa |
| Quantity | 10 μg |
| Cell Type | B Cells; Endothelial Cells; Epithelial Cells; Intestinal Cells; Lymphocytes; Mononuclear Cells; Pluripotent Stem Cells; T Cells |
| Purity or Quality Grade | ≥95% |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction